Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: An analysis of the AIO KRK-0104 trial

Journal of Cancer Research and Clinical Oncology

Volumn 140, Issue 9, 2014, Pages 1607-1614

  Von Einem, J C ^a   Heinemann, V ^a   Von Weikersthal, L Fischer ^b   Vehling Kaiser, U ^c   Stauch, M ^d   Hass, H G ^e   Decker, T ^f   Klein, S ^g   Held, S ^h   Jung, A ⁱ   Kirchner, T ⁱ   Haas, M ^a   Holch, J ^a   Michl, M ^a   Aubele, P ^a   Boeck, S ^a   Schulz, C ^a   Giessen, C ^a   Stintzing, S ^a   Modest, D P ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b KLINIKUM ST MARIEN   (Germany)

^c Onkologische Praxis   (Germany)

^d Onkologische Schwerpunktpraxis   (Germany)

^e Paracelsus Klinik Scheidegg   (Germany)

^f Onkologie Ravensburg   (Germany)

^g INSTITUTE OF PATHOLOGY   (Germany)

^h CLINASSESS GMBH   (Germany)

ⁱ UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CODON; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RAS PROTEINS;

EID: 84908339502     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1678-3     Document Type: Article

References (20)